MedTrace Logo

Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion

NCT02739685 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2019-09-26

No results posted yet for this study

Summary

The purpose of the current study is to demonstrate non-inferiority of everolimus-eluting bioresorbable vascular scaffold to everolimus-eluting stents in patients with chronic total occlusion regarding the antirestenotic efficacy at 8 to 10-month angiographic follow-up.

Conditions

Interventions

DEVICE

Everolimus-eluting bioresorbable vascular scaffold

Implantation of everolimus-eluting bioresorbable vascular scaffold in chronic total occlusion

DEVICE

Everolimus-eluting stent

Implantation of everolimus-eluting stent in chronic total occlusion

Sponsors & Collaborators

  • University of Luebeck

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02739685 on ClinicalTrials.gov